United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs.
Ratings
5 / 5
1 rating in the last 12 months
5
4
3
2
1
CEO
Dr. Martine A. Rothblatt$11.2B
Market Cap • 24/04/20241996
(há 28 anos)
1999
(25 years ago)
NASDAQ
Listagem
Silver Spring
Sede • Maryland985
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
UTHRSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.